| FASD | Fetal alcohol spectrum disorders |
| ROS | Reactive oxygen species |
| FAS | Fetal alcohol syndrome |
| ARND | Alcohol-related neurodevelopmental disorder |
| ARBD | Alcohol-related birth defects |
| PAE | Prenatal ethanol exposure |
| ND-PAE | Neurobehavioral disorder associated with prenatal alcohol exposure |
| NCCs | Neural crest cells |
| Nrf2/Keap1 | Nuclear factor erythroid 2–related factor 2/Kelch-like ECH-associated protein 1 |
| MAPK | Mitogen-activated protein kinase |
| PI3K/Akt | Phosphoinositide 3-kinase/Protein kinase B |
| NF-κB | Nuclear factor kappa-light-chain-enhancer of activated B cells |
| Wnt/β-catenin | Wingless/Integrated/β-catenin |
| mTOR | Mechanistic target of rapamycin |
| ADH | Alcohol dehydrogenase |
| MEOS | Microsomal ethanol-oxidizing system |
| CYP2E1 | Cytochrome P450 2E1 |
| NOX | NADPH oxidase |
| SOD | Superoxide dismutase |
| GPx | Glutathione peroxidase |
| CAT | Catalase |
| GSH | Glutathione |
| MDA | Malondialdehyde |
| NADH | Nicotinamide adenine dinucleotide |
| tBHQ | Tert-butylhydroquinone |
| SFN | Sulforaphane |
| CaMKII | Ca2+/calmodulin-dependent protein kinase II |
| MPT | Mitochondrial permeability transition |
| 8-OHdG | 8-hydroxy-2′-deoxyguanosine |
| JNK | C-Jun N-terminal kinase |
| ERK | Extracellular signal-regulated kinase |
| IκB | Inhibitor of κB |
| IKK | IκB kinase |
| EGCG | Epigallocatechin gallate |
| ER | Endoplasmic reticulum |
| CBD | Cannabidiol |
| D3T | 3H-1,2-dithiole-3-thione |